Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


International News In Brief

This article was originally published in The Gray Sheet

Executive Summary

China to harmonize UDIs, nomenclature: Officials from China's State Food and Drug Administration (SFDA) agree to harmonize with international standards in developing unique device identifiers and medical device nomenclature, AdvaMed announces April 22. SFDA also pledged to work with U.S. device firms during implementation of China's new adverse event reporting regulation at the recently concluded discussions of the U.S.-China Joint Commission on Commerce and Trade's Pharmaceuticals and Medical Devices Subgroup. Chinese and U.S. officials will continue talks on ways to harmonize regulations at a Medical Device Task Force Meeting in China this fall


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts